NCT00235105View on ClinicalTrials.gov

D2E7-Early AS

PHASE2/PHASE3UnknownINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

June 30, 2007

Conditions

Ankylosing Spondylitis

Interventions

DRUG

Adalimumab 40 mg sc every other week

Trial Locations (2)

12200

Charité Campus Benjamin Franklin, Rheumatology, Berlin

44625

Rheumazentrum Ruhrgebiet, Herne

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER